In MPN patient bone marrow biopsy samples with JAK2V617F or KITD816V mutation, increase in phosphorylation of AKT indicates constitutive activation of the PI3K pathway [64]. The gene discussed is PIK3CA; the disease is myeloproliferative disorder.